Novartis strikes a $1.9B partnership with Antares Therapeutics to tackle “undruggable” cancer targets.
Novartis has entered into a strategic collaboration and license agreement with Antares Therapeutics to discover and develop next-generation small molecule oncology treatments. The transaction...
Novaspire Biosciences and Abhinavayan Biotech Announce Strategic Leadership and Core Partnership
Novaspire Biosciences, a premier clinical research organization, announced a strategic evolution in its leadership and ownership structure through a core partnership with Abhinavayan Biotech. This collaboration marks...
FDA Reaches Out to Indian Pharma Amid Critical Ifosfamide Shortage in U.S.
A chemotherapy drug that stands between cancer patients and their treatment has gone dangerously scarce in the United States, compelling federal health regulators to...
Department of Pharmaceuticals urges Stakeholders to Submit Comments on Medical Device GTE Exemption List by July 15
The Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilizers, has officially invited comments from stakeholders regarding proposed amendments to the Global Tender...
CDSCO Clarifies Approval Rules for Granules & Pellets, Bringing Regulatory Clarity to Pharma Industry
The Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services, has issued a comprehensive circular clarifying the regulatory and licensing...
Maiva Pharma launches brand-new, 22-acre sterile injectables plant in Tamil Nadu
Maiva Pharma Private Limited, a leading US FDA-approved sterile injectables manufacturer, has officially inaugurated its brand-new manufacturing plant. Spanning a sprawling 22-acre campus in Shoolagiri, Tamil Nadu, the...
